Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Aiming for remission in adults with attention-deficit/hyperactivity disorder: The primary care goal.

Mattingly G, Culpepper L, Babcock T, Arnold V.

Postgrad Med. 2015 Apr;127(3):323-9. doi: 10.1080/00325481.2015.1012481. Epub 2015 Feb 8. Review.

PMID:
25662296
2.

Natural killer cell responses to dendritic cells infected by the ANRS HIV-1 vaccine candidate, MVAHIV.

Cummings JS, Moreno-Nieves UY, Arnold V, Gilbert A, Yarbrough K, Didier C, Lévy Y, Barré-Sinoussi F, Scott-Algara D; ANRS HIV Vaccine Network (AHVN).

Vaccine. 2014 Sep 29;32(43):5577-84. doi: 10.1016/j.vaccine.2014.07.094. Epub 2014 Aug 13.

PMID:
25131736
3.

In vivo analysis of hyaloid vasculature morphogenesis in zebrafish: A role for the lens in maturation and maintenance of the hyaloid.

Hartsock A, Lee C, Arnold V, Gross JM.

Dev Biol. 2014 Oct 15;394(2):327-39. doi: 10.1016/j.ydbio.2014.07.024. Epub 2014 Aug 13.

4.

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.

Grinsztejn B, De Castro N, Arnold V, Veloso VG, Morgado M, Pilotto JH, Brites C, Madruga JV, Barcellos NT, Santos BR, Vorsatz C, Fagard C, Santini-Oliveira M, Patey O, Delaugerre C, Chêne G, Molina JM; ANRS 12 180 Reflate TB study group.

Lancet Infect Dis. 2014 Jun;14(6):459-67. doi: 10.1016/S1473-3099(14)70711-X. Epub 2014 Apr 9. Erratum in: Lancet Infect Dis. 2014 Jun;14(6):448.

PMID:
24726095
5.

Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design.

Richert L, Doussau A, Lelièvre JD, Arnold V, Rieux V, Bouakane A, Lévy Y, Chêne G, Thiébaut R; Vaccine Research Institute (VRI).

Trials. 2014 Feb 26;15:68. doi: 10.1186/1745-6215-15-68.

6.

S100A9 protein is a novel ligand for the CD85j receptor and its interaction is implicated in the control of HIV-1 replication by NK cells.

Arnold V, Cummings JS, Moreno-Nieves UY, Didier C, Gilbert A, Barré-Sinoussi F, Scott-Algara D.

Retrovirology. 2013 Oct 24;10:122. doi: 10.1186/1742-4690-10-122.

7.

ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years.

López FA, Childress A, Adeyi B, Dirks B, Babcock T, Scheckner B, Lasser R, Shepski J, Arnold V.

J Atten Disord. 2013 Feb 13. [Epub ahead of print]

PMID:
23407278
8.

The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial.

Childress AC, Arnold V, Adeyi B, Dirks B, Babcock T, Scheckner B, Lasser R, Lopez FA.

J Atten Disord. 2014 Feb;18(2):123-32. doi: 10.1177/1087054712448252. Epub 2012 Jun 26.

PMID:
22740112
9.

A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD.

Arnold VK, Feifel D, Earl CQ, Yang R, Adler LA.

J Atten Disord. 2014 Feb;18(2):133-44. doi: 10.1177/1087054712441969. Epub 2012 May 22.

PMID:
22617860
10.

Practice Parameter for psychodynamic psychotherapy with children.

Kernberg PF, Ritvo R, Keable H; American Academy of Child an Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI).

J Am Acad Child Adolesc Psychiatry. 2012 May;51(5):541-57. doi: 10.1016/j.jaac.2012.02.015.

11.

Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.

Weisler RH, Pandina GJ, Daly EJ, Cooper K, Gassmann-Mayer C; 31001074-ATT2001 Study Investigators.

CNS Drugs. 2012 May 1;26(5):421-34. doi: 10.2165/11631990-000000000-00000.

PMID:
22519922
12.

Multimodal nutritional rehabilitation improves clinical outcomes of malnourished patients with chronic respiratory failure: a randomised controlled trial.

Pison CM, Cano NJ, Chérion C, Caron F, Court-Fortune I, Antonini MT, Gonzalez-Bermejo J, Meziane L, Molano LC, Janssens JP, Costes F, Wuyam B, Similowski T, Melloni B, Hayot M, Augustin J, Tardif C, Lejeune H, Roth H, Pichard C; IRAD Investigators.

Thorax. 2011 Nov;66(11):953-60. doi: 10.1136/thx.2010.154922. Epub 2011 Jun 23.

PMID:
21700760
13.

[Initiation of domiciliary non-invasive ventilation: proposals of the Casavni working party].

Rabec C, Gonzalez-Bermejo J, Arnold V, Rouault S, Gillet V, Perrin C, Alluin F, Muir JF, Veale D.

Rev Mal Respir. 2010 Oct;27(8):874-89. doi: 10.1016/j.rmr.2010.08.008. Review. French.

PMID:
20965402
14.

Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).

Suppes T, Vieta E, Liu S, Brecher M, Paulsson B; Trial 127 Investigators.

Am J Psychiatry. 2009 Apr;166(4):476-88. doi: 10.1176/appi.ajp.2008.08020189. Epub 2009 Mar 16.

PMID:
19289454
15.
16.

Evaluation of at-home phlebotomy for iron overload: feasibility and satisfaction of patients and healthcare workers.

Manea P, Loustaud-Ratti V, Mondary D, Arnold V, Ferley JP, Souris S, Fauchais AL, Liozon E, Vidal E.

Gastroenterol Clin Biol. 2008 Feb;32(2):172-9.

PMID:
18496893
17.

The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cells.

Scott-Algara D, Arnold V, Didier C, Kattan T, Pirozzi G, Barré-Sinoussi F, Pancino G.

PLoS One. 2008 Apr 9;3(4):e1975. doi: 10.1371/journal.pone.0001975.

18.

Practice parameter for the assessment and treatment of children and adolescents with substance use disorders.

Bukstein OG, Bernet W, Arnold V, Beitchman J, Shaw J, Benson RS, Kinlan J, McClellan J, Stock S, Ptakowski KK; Work Group on Quality Issues.

J Am Acad Child Adolesc Psychiatry. 2005 Jun;44(6):609-21.

PMID:
15908844
19.

Practice parameter for the assessment and treatment of children and adolescents with enuresis.

Fritz G, Rockney R, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S, Kroeger Ptakowski K; Work Group on Quality Issues; AACAP.

J Am Acad Child Adolesc Psychiatry. 2004 Dec;43(12):1540-50. Review.

PMID:
15564822
20.

Practice parameter for use of electroconvulsive therapy with adolescents.

Ghaziuddin N, Kutcher SP, Knapp P, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S, Kroeger Ptakowski K; Work Group on Quality Issues; AACAP.

J Am Acad Child Adolesc Psychiatry. 2004 Dec;43(12):1521-39. Review.

PMID:
15564821
Items per page

Supplemental Content

Loading ...
Write to the Help Desk